Imatinib mesylate cocrystals: synthesis, screening, and preliminary characterization

被引:0
|
作者
Miroslav Veverka
Peter Šimon
Ján Gallovič
Vladimír Jorík
Eva Veverková
Tibor Dubaj
机构
[1] BelNovamann Ltd.,Research and Development Department
[2] Institute of Physical Chemistry and Chemical Physics,Faculty of Chemical and Food Technology
[3] Slovak University of Technology,Faculty of Chemical and Food Technology
[4] Institute of Inorganic Chemistry,Faculty of Natural Sciences
[5] Slovak University of Technology,undefined
[6] Comenius University,undefined
关键词
Imatinib mesylate; Pharmaceutical cocrystal; Cogrinding; Cocrystallization; Combination drug therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1405 / 1415
页数:10
相关论文
共 50 条
  • [1] Imatinib mesylate cocrystals: synthesis, screening, and preliminary characterization
    Veverka, Miroslav
    Simon, Peter
    Gallovic, Jan
    Jorik, Vladimir
    Veverkova, Eva
    Dubaj, Tibor
    MONATSHEFTE FUR CHEMIE, 2012, 143 (10): : 1405 - 1415
  • [2] Edaravone cocrystals: synthesis, screening, and preliminary characterization
    Veverka, Miroslav
    Dubaj, Tibor
    Gallovic, Jan
    Svajdlenka, Emil
    Meluchova, Beata
    Jorik, Vladimir
    Simon, Peter
    MONATSHEFTE FUR CHEMIE, 2013, 144 (09): : 1335 - 1349
  • [3] Edaravone cocrystals: synthesis, screening, and preliminary characterization
    Miroslav Veverka
    Tibor Dubaj
    Ján Gallovič
    Emil Švajdlenka
    Beáta Meľuchová
    Vladimír Jorík
    Peter Šimon
    Monatshefte für Chemie - Chemical Monthly, 2013, 144 : 1335 - 1349
  • [4] Cocrystals of quercetin: synthesis, characterization, and screening of biological activity
    Veverka, Miroslav
    Dubaj, Tibor
    Gallovic, Jan
    Jorik, Vladimir
    Veverkova, Eva
    Danihelova, Martina
    Simon, Peter
    MONATSHEFTE FUR CHEMIE, 2015, 146 (01): : 99 - 109
  • [5] Cocrystals of quercetin: synthesis, characterization, and screening of biological activity
    Miroslav Veverka
    Tibor Dubaj
    Ján Gallovič
    Vladimír Jorík
    Eva Veverková
    Martina Danihelová
    Peter Šimon
    Monatshefte für Chemie - Chemical Monthly, 2015, 146 : 99 - 109
  • [6] Imatinib mesylate - synthesis and preparation of polymorphs
    Szczepek, Wojciech J.
    PRZEMYSL CHEMICZNY, 2006, 85 (05): : 306 - 309
  • [7] Imatinib Mesylate: An Optimization in its Synthesis
    Boechat, Nubia
    Bastos, Monica M.
    Duarte, Silvio Luiz
    Costa, Jorge Carlos dos S.
    Mafra, Joao Carlos M.
    Daniel, Lucilene da C. C.
    REVISTA VIRTUAL DE QUIMICA, 2013, 5 (02) : 222 - 234
  • [8] Characterization and Solubility Studies of Pharmaceutical Cocrystals of Eprosartan Mesylate
    Bhandaru, Jaswanth S.
    Malothu, Narender
    Akkinepally, Raghuram R.
    CRYSTAL GROWTH & DESIGN, 2015, 15 (03) : 1173 - 1179
  • [9] Imatinib mesylate in chordoma
    Casali, PG
    Messina, A
    Stacchiotti, S
    Tamborini, E
    Crippa, F
    Gronchi, A
    Orlandi, R
    Ripamonti, C
    Spreafico, C
    Bertieri, R
    Bertulli, R
    Colecchia, M
    Fumagalli, E
    Greco, A
    Grosso, F
    Olmi, P
    Pierotti, MA
    Pilotti, S
    CANCER, 2004, 101 (09) : 2086 - 2097
  • [10] Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro
    Kroschwald, Lysann Michaela
    Tauer, Josephine Tabea
    Kroschwald, Sonja Ingrid
    Suttorp, Meinolf
    Wiedenfeld, Anne
    Beissert, Stefan
    Bauer, Andrea
    Rauner, Martina
    ONCOLOGY LETTERS, 2019, 18 (02) : 2102 - 2108